XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Xeroderma pigmentosum complementation group C (XPC) protein is crucial for DNA damage repair via nucleotide excision repair.
• Reduced XPC expression correlates with poor prognosis in non-small cell lung cancer (NSCLC).
• Mechanisms linking XPC loss to lung cancer progression remain largely unknown.

Purpose of the Study:

• To investigate the functional role of XPC in non-small cell lung cancer (NSCLC) progression.
• To elucidate the molecular mechanisms by which XPC silencing affects NSCLC cell behavior.
• To identify potential therapeutic targets based on XPC's role in lung cancer.

Main Methods:

• Utilized XPC knockdown models in NSCLC cell lines with epithelial phenotypes.
• Assessed cell proliferation and migration rates in vitro and in vivo.
• Quantified E-Cadherin expression levels and analyzed downstream signaling pathways (ERK, Snail).
• Performed E-Cadherin restoration experiments to validate its role.

Main Results:

• XPC silencing significantly enhanced NSCLC cell proliferation and migration.
• Decreased E-Cadherin expression was observed upon XPC knockdown.
• Restoring E-Cadherin expression reversed the pro-proliferative and pro-migratory effects of XPC knockdown.
• XPC loss was found to activate the ERK pathway and upregulate Snail, leading to E-Cadherin repression.

Conclusions:

• XPC silencing promotes NSCLC progression by down-regulating E-Cadherin expression.
• The ERK/Snail pathway mediates the repression of E-Cadherin by XPC loss.
• Reduced E-Cadherin due to low XPC expression contributes to the poor prognosis observed in NSCLC patients.